{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T05:13:40Z","timestamp":1736313220196,"version":"3.32.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-024-01137-0","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T03:06:55Z","timestamp":1736219215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of Covid-19 on harm reduction policies in Iran: an interrupted time series analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Siavash","family":"Beiranvand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meysam","family":"Behzadifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidin","family":"Aryankhesal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Jafar","family":"Ehsanzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Behzadifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"issue":"12","key":"1137_CR1","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1080\/17441692.2022.2129720","volume":"17","author":"SV Aronowitz","year":"2022","unstructured":"Aronowitz SV, Carroll JJ, Hansen H, Jauffret-Roustide M, Parker CM, Suhail-Sindhu S, et al. Substance use policy and practice in the COVID-19 pandemic: learning from early pandemic responses through internationally comparative field data. Glob Public Health. 2022;17(12):3654\u201369.","journal-title":"Glob Public Health"},{"key":"1137_CR2","doi-asserted-by":"publisher","first-page":"108374","DOI":"10.1016\/j.jsat.2021.108374","volume":"129","author":"C Russell","year":"2021","unstructured":"Russell C, Ali F, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): a national qualitative study. J Subst Abuse Treat. 2021;129:108374.","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"1137_CR3","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/dar.13456","volume":"41","author":"H Efunnuga","year":"2022","unstructured":"Efunnuga H, Higgs P, Walker S, O\u2019Keefe D. Health service utilisation and access for people who inject drugs during COVID-19. Drug Alcohol Rev. 2022;41(6):1304\u201310.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"1137_CR4","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1186\/s12889-021-12082-z","volume":"21","author":"DT Halperin","year":"2021","unstructured":"Halperin DT, Hearst N, Hodgins S, Bailey RC, Klausner JD, Jackson H, et al. Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here. BMC Public Health. 2021;21(1):2084.","journal-title":"BMC Public Health"},{"issue":"2","key":"1137_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.pec.2021.09.006","volume":"105","author":"D Kemp","year":"2022","unstructured":"Kemp D, King AJ, Upshaw SJ, Mackert M, Jensen JD. Applying harm reduction to COVID-19 prevention: the influence of moderation messages and risk infographics. Patient Educ Couns. 2022;105(2):269\u201376.","journal-title":"Patient Educ Couns"},{"issue":"4","key":"1137_CR6","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.3390\/ijerph19042230","volume":"19","author":"RS Bolinski","year":"2022","unstructured":"Bolinski RS, Walters S, Salisbury-Afshar E, Ouellet LJ, Jenkins WD, Almirol E, et al. The impact of the COVID-19 pandemic on Drug Use behaviors, Fentanyl exposure, and Harm Reduction Service support among people who use drugs in rural settings. Int J Environ Res Public Health. 2022;19(4):2230.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"1137_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13011-023-00521-6","volume":"18","author":"E Gubskaya","year":"2023","unstructured":"Gubskaya E, Kennedy MC, Hayashi K, Cui Z, Milloy MJ, Kerr T. The impact of the COVID-19 pandemic on access to supervised consumption programs. Subst Abuse Treat Prev Policy. 2023;18(1):16.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"3","key":"1137_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1192\/bji.2022.1","volume":"19","author":"VL Narasimha","year":"2022","unstructured":"Narasimha VL, Butner JL, Hanafi E, Farokhnia M, Bhad R, Chalabianloo F, et al. Harm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic: a global perspective. BJPsych Int. 2022;19(3):66\u20139.","journal-title":"BJPsych Int"},{"key":"1137_CR9","doi-asserted-by":"publisher","first-page":"103076","DOI":"10.1016\/j.drugpo.2020.103076","volume":"90","author":"M Olding","year":"2021","unstructured":"Olding M, Barker A, McNeil R, Boyd J. Essential work, precarious labour: the need for safer and equitable harm reduction work in the era of COVID-19. Int J Drug Policy. 2021;90:103076.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1137_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1186\/s12889-022-12873-y","volume":"22","author":"J Schofield","year":"2022","unstructured":"Schofield J, Dumbrell J, Matheson C, Parkes T, Bancroft A. The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study. BMC Public Health. 2022;22(1):500.","journal-title":"BMC Public Health"},{"issue":"1","key":"1137_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12954-020-00452-6","volume":"17","author":"A Davitadze","year":"2020","unstructured":"Davitadze A, Meylakhs P, Lakhov A, King EJ. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work. Harm Reduct J. 2020;17(1):98.","journal-title":"Harm Reduct J"},{"key":"1137_CR12","doi-asserted-by":"publisher","first-page":"102908","DOI":"10.1016\/j.drugpo.2020.102908","volume":"93","author":"M Alavi","year":"2021","unstructured":"Alavi M, Moghanibashi-Mansourieh A, Radfar SR, Alizadeh S, Bahramabadian F, Esmizade S, et al. Coordination, cooperation, and creativity within harm reduction networks in Iran: COVID-19 prevention and control among people who use drugs. Int J Drug Policy. 2021;93:102908.","journal-title":"Int J Drug Policy"},{"issue":"8","key":"1137_CR13","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1016\/S2215-0366(20)30306-0","volume":"7","author":"H Karimi-Sari","year":"2020","unstructured":"Karimi-Sari H, Sharafi H, Rezaee-Zavareh MS, Alavian SM. Harm reduction during the COVID-19 outbreak in Iran. Lancet Psychiatry. 2020;7(8):e57.","journal-title":"Lancet Psychiatry"},{"key":"1137_CR14","doi-asserted-by":"publisher","first-page":"639393","DOI":"10.3389\/fpsyt.2021.639393","volume":"12","author":"SR Radfar","year":"2021","unstructured":"Radfar SR, De Jong CAJ, Farhoudian A, Ebrahimi M, Rafei P, Vahidi M, et al. Reorganization of Substance Use Treatment and Harm Reduction services during the COVID-19 pandemic: A Global Survey. Front Psychiatry. 2021;12:639393.","journal-title":"Front Psychiatry"},{"issue":"1","key":"1137_CR15","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1186\/s12889-023-16879-y","volume":"23","author":"AR Soltanian","year":"2023","unstructured":"Soltanian AR, Ahmaddoost-Razdari R, Mahjub H, Poorolajal J. Impact of COVID-19 Disease Control Committee (CDCC) policies on prevention of the disease using Bayes network inference in west of Iran. BMC Public Health. 2023;23(1):2008.","journal-title":"BMC Public Health"},{"key":"1137_CR16","doi-asserted-by":"publisher","first-page":"104051","DOI":"10.1016\/j.drugpo.2023.104051","volume":"117","author":"AH Behnoush","year":"2023","unstructured":"Behnoush AH, Bazmi E, Forouzesh M, Koehler SA, Monabati SJ, Behnoush B. Impact of COVID-19 on poisoning-related mortality in Iran: an interrupted time series study. Int J Drug Policy. 2023;117:104051.","journal-title":"Int J Drug Policy"},{"issue":"12","key":"1137_CR17","doi-asserted-by":"publisher","first-page":"e053497","DOI":"10.1136\/bmjopen-2021-053497","volume":"11","author":"J Manthey","year":"2021","unstructured":"Manthey J, Jasilionis D, Jiang H, Me\u0161\u010deriakova-Veliulien\u0117 O, Petkevi\u010dien\u0117 J, Radi\u0161auskas R, et al. Interrupted time series analyses to assess the impact of alcohol control policy on socioeconomic inequalities in mortality in Lithuania: a study protocol. BMJ Open. 2021;11(12):e053497.","journal-title":"BMJ Open"},{"issue":"1","key":"1137_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12916-022-02721-6","volume":"21","author":"J Manthey","year":"2023","unstructured":"Manthey J, Jasilionis D, Jiang H, Me\u0161\u010deriakova O, Petkevi\u010dien\u0117 J, Radi\u0161auskas R, et al. The impact of alcohol taxation increase on all-cause mortality inequalities in Lithuania: an interrupted time series analysis. BMC Med. 2023;21(1):22.","journal-title":"BMC Med"},{"key":"1137_CR19","doi-asserted-by":"publisher","first-page":"102875","DOI":"10.1016\/j.drugpo.2020.102875","volume":"84","author":"TS Bartholomew","year":"2020","unstructured":"Bartholomew TS, Tookes HE, Serota DP, Behrends CN, Forrest DW, Feaster DJ. Impact of routine opt-out HIV\/HCV screening on testing uptake at a syringe services program: an interrupted time series analysis. Int J Drug Policy. 2020;84:102875.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"1137_CR20","first-page":"CD011856","volume":"2016","author":"K Frazer","year":"2016","unstructured":"Frazer K, McHugh J, Callinan JE, Kelleher C. Impact of institutional smoking bans on reducing harms and secondhand smoke exposure. Cochrane Database Syst Rev. 2016;2016(5):CD011856.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1137_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/add.14778","volume":"115","author":"A O\u2019Donnell","year":"2020","unstructured":"O\u2019Donnell A, Angus C, Hanratty B, Hamilton FL, Petersen I, Kaner E. Impact of the introduction and withdrawal of financial incentives on the delivery of alcohol screening and brief advice in English primary health care: an interrupted time-series analysis. Addiction. 2020;115(1):49\u201360.","journal-title":"Addiction"},{"key":"1137_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.drugpo.2017.07.033","volume":"50","author":"A Espelt","year":"2017","unstructured":"Espelt A, Villalb\u00ed JR, Bosque-Prous M, Par\u00e9s-Badell O, Mari-Dell\u2019Olmo M, Brugal MT. The impact of harm reduction programs and police interventions on the number of syringes collected from public spaces. A time series analysis in Barcelona, 2004\u20132014. Int J Drug Policy. 2017;50:11\u20138.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1137_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12874-021-01364-0","volume":"21","author":"SL Turner","year":"2021","unstructured":"Turner SL, Forbes AB, Karahalios A, Taljaard M, McKenzie JE. Evaluation of statistical methods used in the analysis of interrupted time series studies: a simulation study. BMC Med Res Methodol. 2021;21(1):181.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"1137_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12874-021-01306-w","volume":"21","author":"SL Turner","year":"2021","unstructured":"Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, McKenzie JE. Comparison of six statistical methods for interrupted time series studies: empirical evaluation of 190 published series. BMC Med Res Methodol. 2021;21(1):134.","journal-title":"BMC Med Res Methodol"},{"key":"1137_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jclinepi.2018.05.026","volume":"103","author":"J Lopez Bernal","year":"2018","unstructured":"Lopez Bernal J, Soumerai S, Gasparrini A. A methodological framework for model selection in interrupted time series studies. J Clin Epidemiol. 2018;103:82\u201391.","journal-title":"J Clin Epidemiol"},{"key":"1137_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2147\/CLEP.S176723","volume":"11","author":"S Hawley","year":"2019","unstructured":"Hawley S, Ali MS, Berencsi K, Judge A, Prieto-Alhambra D. Sample size and power considerations for ordinary least squares interrupted time series analysis: a simulation study. Clin Epidemiol. 2019;11:197\u2013205.","journal-title":"Clin Epidemiol"},{"issue":"8","key":"1137_CR27","doi-asserted-by":"publisher","first-page":"e35729","DOI":"10.2196\/35729","volume":"11","author":"N Stone","year":"2022","unstructured":"Stone N, Bedford R, Newby K, Brown K, Jackson L, Bremner S, et al. Reducing New Chlamydia infection among Young men by promoting correct and consistent condom use: protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2022;11(8):e35729.","journal-title":"JMIR Res Protoc"},{"issue":"4","key":"1137_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11904-021-00562-1","volume":"18","author":"RM Gravett","year":"2021","unstructured":"Gravett RM, Marrazzo JM. HIV and COVID-19: lessons from HIV and STI Harm reduction strategies. Curr HIV\/AIDS Rep. 2021;18(4):261\u201370.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"1137_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12954-022-00699-1","volume":"19","author":"M Bosch-Ar\u00eds","year":"2022","unstructured":"Bosch-Ar\u00eds M, Gasulla L, de Gispert T, Segura L, Colom J. The impact of the COVID-19 pandemic on harm reduction services in Catalonia: the experience of people who use drugs and harm reduction professionals. Harm Reduct J. 2022;19(1):118.","journal-title":"Harm Reduct J"},{"key":"1137_CR30","doi-asserted-by":"publisher","first-page":"103710","DOI":"10.1016\/j.drugpo.2022.103710","volume":"105","author":"A Muller","year":"2022","unstructured":"Muller A, Akiyama MJ, Riback L, Nyakowa M, Musyoki H, Cherutich P, et al. Impact of COVID-19 on substance use disorder treatment services in Kenya: qualitative findings from healthcare providers. Int J Drug Policy. 2022;105:103710.","journal-title":"Int J Drug Policy"},{"key":"1137_CR31","doi-asserted-by":"publisher","first-page":"108246","DOI":"10.1016\/j.jsat.2020.108246","volume":"123","author":"D Frank","year":"2021","unstructured":"Frank D. A chance to do it better: Methadone maintenance treatment in the age of Covid-19. J Subst Abuse Treat. 2021;123:108246.","journal-title":"J Subst Abuse Treat"},{"key":"1137_CR32","doi-asserted-by":"publisher","first-page":"109323","DOI":"10.1016\/j.drugalcdep.2022.109323","volume":"232","author":"CN Behrends","year":"2022","unstructured":"Behrends CN, Lu X, Corry GJ, LaKosky P, Prohaska SM, Glick SN, et al. Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020. Drug Alcohol Depend. 2022;232:109323.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1137_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10461-021-03332-7","volume":"26","author":"MC Frost","year":"2022","unstructured":"Frost MC, Sweek EW, Austin EJ, Corcorran MA, Juarez AM, Frank ND, et al. Program adaptations to provide harm reduction services during the COVID-19 pandemic: a Qualitative Study of Syringe Services Programs in the U.S. AIDS Behav. 2022;26(1):57\u201368.","journal-title":"AIDS Behav"},{"issue":"1","key":"1137_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s42358-021-00200-9","volume":"61","author":"D Cankurtaran","year":"2021","unstructured":"Cankurtaran D, Tezel N, Ercan B, Yildiz SY, Akyuz EU. The effects of COVID-19 fear and anxiety on symptom severity, sleep quality, and mood in patients with fibromyalgia: a pilot study. Adv Rheumatol. 2021;61(1):41.","journal-title":"Adv Rheumatol"},{"issue":"4","key":"1137_CR35","first-page":"E508","volume":"61","author":"MK Ghanbari","year":"2021","unstructured":"Ghanbari MK, Behzadifar M, Bakhtiari A, Behzadifar M, Azari S, Abolghasem Gorji H, et al. Assessing Iran\u2019s health system according to the COVID-19 strategic preparedness and response plan of the World Health Organization: health policy and historical implications. J Prev Med Hyg. 2021;61(4):E508\u201319.","journal-title":"J Prev Med Hyg"},{"issue":"1","key":"1137_CR36","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12913-022-07753-5","volume":"22","author":"R Rezapour","year":"2022","unstructured":"Rezapour R, Dorosti AA, Farahbakhsh M, Azami-Aghdash S, Iranzad I. The impact of the Covid-19 pandemic on primary health care utilization: an experience from Iran. BMC Health Serv Res. 2022;22(1):404.","journal-title":"BMC Health Serv Res"},{"key":"1137_CR37","first-page":"174","volume":"36","author":"M Afkar","year":"2022","unstructured":"Afkar M, Rezanejad Asl P, Mahdavi Hezaveh A, Akrami F, Riazi-Isfahani S, Peykari N, et al. The Effect of the COVID-19 pandemic on Non-communicable Disease Prevention and Management Services in the Primary Health Care System of Iran. Med J Islam Repub Iran. 2022;36:174.","journal-title":"Med J Islam Repub Iran"},{"issue":"1","key":"1137_CR38","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1186\/s12889-021-11285-8","volume":"21","author":"AM Martindale","year":"2021","unstructured":"Martindale AM, Pilbeam C, Mableson H, Tonkin-Crine S, Atkinson P, Borek A, et al. Perspectives on COVID-19 testing policies and practices: a qualitative study with scientific advisors and NHS health care workers in England. BMC Public Health. 2021;21(1):1216.","journal-title":"BMC Public Health"},{"issue":"1","key":"1137_CR39","first-page":"13","volume":"94","author":"M Saki","year":"2021","unstructured":"Saki M, Ghanbari MK, Behzadifar M, Imani-Nasab MH, Behzadifar M, Azari S, et al. The impact of the Social Distancing Policy on COVID-19 incidence cases and deaths in Iran from February 2020 to January 2021: insights from an interrupted Time Series Analysis. Yale J Biol Med. 2021;94(1):13\u201321.","journal-title":"Yale J Biol Med"},{"key":"1137_CR40","doi-asserted-by":"publisher","first-page":"551889","DOI":"10.3389\/fpubh.2020.551889","volume":"8","author":"R Rahmanzade","year":"2020","unstructured":"Rahmanzade R, Rahmanzadeh R, Hashemian SM, Tabarsi P. Iran\u2019s Approach to COVID-19: evolving treatment protocols and ongoing clinical trials. Front Public Health. 2020;8:551889.","journal-title":"Front Public Health"},{"issue":"1","key":"1137_CR41","doi-asserted-by":"publisher","first-page":"e0001494","DOI":"10.1371\/journal.pgph.0001494","volume":"3","author":"D Musoke","year":"2023","unstructured":"Musoke D, Nalinya S, Lubega GB, Deane K, Ekirapa-Kiracho E, McCoy D. The effects of COVID-19 lockdown measures on health and healthcare services in Uganda. PLOS Glob Public Health. 2023;3(1):e0001494.","journal-title":"PLOS Glob Public Health"},{"issue":"3","key":"1137_CR42","doi-asserted-by":"publisher","first-page":"527","DOI":"10.4269\/ajtmh.23-0144","volume":"109","author":"B Bose","year":"2023","unstructured":"Bose B, Alam SA, P\u00f6rtner CC. Impacts of the COVID-19 lockdown on Healthcare Inaccessibility and Unaffordability in Uganda. Am J Trop Med Hyg. 2023;109(3):527\u201335.","journal-title":"Am J Trop Med Hyg"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01137-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-024-01137-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01137-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T05:03:38Z","timestamp":1736226218000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-024-01137-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1137"],"URL":"https:\/\/doi.org\/10.1186\/s12954-024-01137-0","relation":{},"ISSN":["1477-7517"],"issn-type":[{"type":"electronic","value":"1477-7517"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"9 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Lorestan University of Medical Sciences (IR.LUMS.REC.1402.296).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}